Literature DB >> 28210378

Advances in Vitiligo: An Update on Medical and Surgical Treatments.

Alexander B Dillon1, Andrew Sideris1, Ali Hadi1, Nada Elbuluk1.   

Abstract

Vitiligo is one of the most common cutaneous disorders of depigmentation. Although its underlying causes are still being studied and no definitive cure currently exists, recent research has provided insight into pathogenic mechanisms and new treatment options. Objective: The aim of this paper is to provide a comprehensive overview of the medical and surgical therapies for vitiligo with emphasis on the most recent treatment modalities. Design: This review was conducted through a literature search using PubMed and the National institutes of Health's clinicalTrials.gov databases from January 2010 to July 2015. This yielded 86 studies, 12 of which were excluded, and 74 of which were reviewed.
Results: Recent studies and ongoing clinical trials indicate that there are many promising new medical and surgical treatment modalities for this chronic condition.
Conclusion: A combination of traditional and newer treatments may work synergistically to provide additional improvement in patients' disease state and quality of life.

Entities:  

Year:  2017        PMID: 28210378      PMCID: PMC5300730     

Source DB:  PubMed          Journal:  J Clin Aesthet Dermatol        ISSN: 1941-2789


  72 in total

1.  A comparative study on efficacy of UVA1 vs. narrow-band UVB phototherapy in the treatment of vitiligo.

Authors:  Bakr Mohamed El-Zawahry; Dalia Ahmed Bassiouny; Rehab Mohamed Sobhi; Eman Abdel-Aziz; Naglaa Sameh Zaki; Dawoud Fakhry Habib; Dalia Mamdouh Shahin
Journal:  Photodermatol Photoimmunol Photomed       Date:  2012-04       Impact factor: 3.135

Review 2.  Topical treatment in vitiligo and the potential uses of new drug delivery systems.

Authors:  Bhawna Jain Garg; Abir Saraswat; Amit Bhatia; Om Prakash Katare
Journal:  Indian J Dermatol Venereol Leprol       Date:  2010 May-Jun       Impact factor: 2.545

3.  Potential advantages of simvastatin as a novel anti-vitiligo arsenal.

Authors:  A Feily; D Baktash; A Mohebbipour; A Feily
Journal:  Eur Rev Med Pharmacol Sci       Date:  2013-07       Impact factor: 3.507

4.  Melanocytes transplantation in patients with vitiligo using needling micrografting technique.

Authors:  Khalifa E Sharquie; Adil A Noaimi; Hana A Al-Mudaris
Journal:  J Drugs Dermatol       Date:  2013-05       Impact factor: 2.114

5.  Treatment of stable vitiligo by ReCell system.

Authors:  Valerio Cervelli; Barbara De Angelis; Alberto Balzani; Gianfranco Colicchia; Diana Spallone; Monica Grimaldi
Journal:  Acta Dermatovenerol Croat       Date:  2009       Impact factor: 1.256

6.  Efficacy and safety of autologous cultured melanocytes delivered on poly (DL-lactic acid) film: a prospective, open-label, randomized, multicenter study.

Authors:  Deepa Ghosh; Pushpa Kuchroo; Chandra Viswanathan; Shailendra Sachan; Bela Shah; Deepa Bhatt; Shrichand Parasramani; Satish Savant
Journal:  Dermatol Surg       Date:  2012-10-01       Impact factor: 3.398

7.  Effectiveness of 0.1% topical tacrolimus in adult and children patients with vitiligo.

Authors:  Montree Udompataikul; Pairutch Boonsupthip; Rungthiwa Siriwattanagate
Journal:  J Dermatol       Date:  2010-11-02       Impact factor: 4.005

8.  Comparison of efficacy of narrow band UVB therapies with UVB alone, in combination with calcipotriol, and with betamethasone and calcipotriol in vitiligo.

Authors:  Necmettin Akdeniz; Ibrahim Halil Yavuz; Serap Gunes Bilgili; Goknur Ozaydın Yavuz; Omer Calka
Journal:  J Dermatolog Treat       Date:  2013-05-06       Impact factor: 3.359

9.  The efficacy of afamelanotide and narrowband UV-B phototherapy for repigmentation of vitiligo.

Authors:  Pearl E Grimes; Iltefat Hamzavi; Mark Lebwohl; Jean Paul Ortonne; Henry W Lim
Journal:  JAMA Dermatol       Date:  2013-01       Impact factor: 10.282

Review 10.  Statins: novel additions to the dermatologic arsenal?

Authors:  M R Namazi
Journal:  Exp Dermatol       Date:  2004-06       Impact factor: 3.960

View more
  3 in total

Review 1.  Involvement of adenylate cyclase/cAMP/CREB and SOX9/MITF in melanogenesis to prevent vitiligo.

Authors:  Navneet Arora; Ehraz Mehmood Siddiqui; Sidharth Mehan
Journal:  Mol Cell Biochem       Date:  2021-01-03       Impact factor: 3.396

Review 2.  Surgical Treatment of Vitiligo.

Authors:  Alicja Frączek; Marta Kasprowicz-Furmańczyk; Waldemar Placek; Agnieszka Owczarczyk-Saczonek
Journal:  Int J Environ Res Public Health       Date:  2022-04-15       Impact factor: 4.614

Review 3.  The Role of MicroRNAs in Vitiligo: Regulators and Therapeutic Targets.

Authors:  Lili Li
Journal:  Ann Dermatol       Date:  2020-11-11       Impact factor: 1.444

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.